{"data":[{"accessionNo":"0001445546-26-008019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Common","eventDate":"2026-09-30","reportingPerson":"The Charger Corporation","reportingCik":null,"personType":"HC","sharesOwned":3023033,"percentOfClass":5.09,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001445546-26-008019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Common","eventDate":"2026-09-30","reportingPerson":"First Trust Advisors L.P.","reportingCik":null,"personType":"IA","sharesOwned":3023033,"percentOfClass":5.09,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001445546-26-008019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Common","eventDate":"2026-09-30","reportingPerson":"First Trust Portfolios L.P.","reportingCik":null,"personType":"BD","sharesOwned":3023033,"percentOfClass":5.09,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000107","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-09-30","reportingPerson":"Bank of New York Mellon Corp","reportingCik":null,"personType":"HC","sharesOwned":5118575,"percentOfClass":8.6,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000107","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-09-30","reportingPerson":"BNY Mellon IHC, LLC","reportingCik":null,"personType":"HC","sharesOwned":4433440,"percentOfClass":7.5,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000107","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-09-30","reportingPerson":"MBC Investments Corp","reportingCik":null,"personType":"HC","sharesOwned":4433440,"percentOfClass":7.5,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000107","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-09-30","reportingPerson":"Newton Investment Management North America, LLC","reportingCik":null,"personType":"IA","sharesOwned":3926610,"percentOfClass":6.6,"filedAt":"2026-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0002012383-26-001861","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001308547","issuerName":"DOLBY LABORATORIES, INC","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Stock","eventDate":"2026-05-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6041219,"percentOfClass":10,"filedAt":"2026-06-04","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000895421-26-000141","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":5020777,"percentOfClass":8.2,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000895421-26-000141","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"Atlanta Capital Management Company, LLC","reportingCik":null,"personType":"IA,CO","sharesOwned":3925085,"percentOfClass":6.4,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0002100121-26-000263","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001308547","issuerName":"Dolby Laboratories Inc","ticker":"DLB","cusip":"25659T107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":5019900,"percentOfClass":8.24,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0002100119-26-000461","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001308547","issuerName":"Dolby Laboratories Inc","ticker":"DLB","cusip":"25659T107","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":3193409,"percentOfClass":5.24,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"Bank of New York Mellon Corp","reportingCik":null,"personType":"HC","sharesOwned":4499820,"percentOfClass":7.4,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"MBC Investments Corp","reportingCik":null,"personType":"HC","sharesOwned":3791098,"percentOfClass":6.2,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"BNY Mellon IHC, LLC","reportingCik":null,"personType":"HC","sharesOwned":3791098,"percentOfClass":6.2,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001390777-26-000045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":"25659T107","securityClass":"Class A Common Stock","eventDate":"2026-03-31","reportingPerson":"Newton Investment Management North America, LLC","reportingCik":null,"personType":"IA","sharesOwned":3275399,"percentOfClass":5.4,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000102909-26-001135","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001308547","issuerName":"Dolby Laboratories Inc","ticker":"DLB","cusip":"25659T107","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby","reportingCik":"0001537372","personType":"IN","sharesOwned":34368358,"percentOfClass":36,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"David E. Dolby","reportingCik":null,"personType":"IN","sharesOwned":33615951,"percentOfClass":35.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby, as Trustee of the Marital Trust under the Dolby Family Trust Instrument dated May 7, 1999","reportingCik":null,"personType":"OO","sharesOwned":24108162,"percentOfClass":25.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby, as Trustee of the Dagmar Dolby Trust under the Dolby Family Trust Instrument dated May 7, 1999","reportingCik":"0001598813","personType":"OO","sharesOwned":7682117,"percentOfClass":8,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dolby Holdings II LLC","reportingCik":null,"personType":"OO","sharesOwned":1040000,"percentOfClass":1.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Thomas E. Dolby","reportingCik":null,"personType":"IN","sharesOwned":680592,"percentOfClass":0.7,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust B dated April 19, 2002","reportingCik":null,"personType":"OO","sharesOwned":463262,"percentOfClass":0.5,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby, as Trustee of the Dagmar Dolby 2016 Trust B dated March 23, 2016","reportingCik":null,"personType":"OO","sharesOwned":403600,"percentOfClass":0.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dolby Holdings III LLC","reportingCik":null,"personType":"OO","sharesOwned":350000,"percentOfClass":0.4,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0001193125-26-051828","formType":"SCHEDULE 13D/A","amendmentNo":55,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2026-02-11","reportingPerson":"Dagmar Dolby, as Trustee of the Ray Dolby 2002 Trust A dated April 19, 2002","reportingCik":"0001316241","personType":"OO","sharesOwned":160592,"percentOfClass":0.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000895421-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":6192241,"percentOfClass":10.2,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000895421-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"Atlanta Capital Management Company, LLC","reportingCik":null,"personType":"IA,CO","sharesOwned":5226244,"percentOfClass":8.6,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"},{"accessionNo":"0000895421-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001308547","issuerName":"Dolby Laboratories, Inc.","ticker":"DLB","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-12-31","reportingPerson":"Eaton Vance Atlanta Capital SMID-Cap Fund","reportingCik":null,"personType":"IV","sharesOwned":3965479,"percentOfClass":6.5,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/dlb"}],"updatedAt":"2026-11-03T22:31:50.891Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/dlb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}